Intuitive Surgical Inc (ISRG) |
|
Price: $392.6200
$-3.66
-0.924%
|
Day's High:
| $401.27
| Week Perf:
| 0.83 %
|
Day's Low: |
$ 397.18 |
30 Day Perf: |
3.27 % |
Volume (M): |
88 |
52 Wk High: |
$ 403.00 |
Volume (M$): |
$ 35,161 |
52 Wk Avg: |
$317.09 |
Open: |
$399.60 |
52 Wk Low: |
$237.58 |
|
|
Market Capitalization (Millions $) |
140,344 |
Shares
Outstanding (Millions) |
357 |
Employees |
9,793 |
Revenues (TTM) (Millions $) |
7,124 |
Net Income (TTM) (Millions $) |
1,817 |
Cash Flow (TTM) (Millions $) |
1,169 |
Capital Exp. (TTM) (Millions $) |
1,064 |
Intuitive Surgical Inc
Intuitive Surgical, Inc. was founded in 1995. We are a Delaware corporation with
our corporate headquarters located at 1266 Kifer Road, Sunnyvale, California 94086.
Our telephone number is (408) 523-2100, and our website address is www.intuitivesurgical.com
. In this report, “Intuitive Surgical,” “we,” “us,”
and “our” refer to Intuitive Surgical, Inc. and its subsidiaries.
Intuitive®, da Vinci®, da Vinci®S™, TilePro™, Solo Surgery™,
EndoWrist®, InSite®, AESOP®, HERMES®, ZEUS®, SOCRATES™
and Navigator™ are trademarks of Intuitive Surgical, Inc.
We design, manufacture and market the da Vinci Surgical Systems, which are
advanced surgical systems that we believe, represent a new generation of surgery.
We believe that this new generation of surgery, which we call da Vinci surgery,
is a revolutionary advancement similar in scope to previous generations of surgery—open
surgery and minimally invasive surgery, or MIS. Our da Vinci Surgical Systems
consist of a surgeon’s console, a patient-side cart, a high performance
vision system and proprietary “wristed” instruments and surgical
accessories. By placing computer-enhanced technology between the surgeon and
patient, we believe that our systems enable surgeons to perform advanced MIS
in a manner never before experienced. The da Vinci Surgical System controls
Intuitive Surgical endoscopic instruments, including rigid endoscopes, blunt
and sharp endoscopic dissectors, scissors, scalpels, forceps/pickups, needle
holders, endoscopic retractors, electrocautery, ultrasonic cutters, and accessories
during a wide range of surgical procedures. The da Vinci Surgical System seamlessly
translates the surgeon’s natural hand movements on instrument controls
at the console into corresponding micro-movements of instruments positioned
inside the patient through small puncture incisions, or ports. Our da Vinci
Surgical System provides the surgeon with the intuitive control, range of motion,
fine tissue manipulation capability and 3-D vision characteristic of open surgery,
while simultaneously allowing the surgeon to work through the small ports of
MIS.
In March 1997, surgeons using an early prototype of our technology successfully
performed the first da Vinci surgery on humans. In the second quarter of 1999,
we began selling da Vinci products and services outside the United States. In
July 2000, we obtained clearance from the U.S. Food and Drug Administration
(FDA) to market our products in the United States for use in General laparoscopic
procedures.
Our goal is to establish da Vinci surgery as the standard approach for complex
surgical procedures, displacing both open surgical technique and standard MIS
within this segment. We intend to accomplish this objective both by pioneering
new types of endoscopic surgery and by making existing MIS procedures easier,
safer and more cost-effective than the alternative methods. Our strategy is
to broaden the number of procedures performed using the da Vinci Surgical System
and to educate surgeons, hospitals and patients as to the benefits of da Vinci
surgery.
Sales and Customer Support
We market our products through a direct sales force in the United States and
parts of Europe. We also market our products outside the United States through
distributors. Our direct sales force is comprised of sales managers, clinical
sales representatives, training specialists, and technical service representatives.
Sales activities include educating surgeons and hospital staff across multiple
surgical specialties on the advantages of da Vinci surgery and the clinical
applications that our technology enables. We also train our sales force to educate
hospital management on the potential benefits of adopting our technology, including
the potential for increased local market share that may result from offering
da Vinci surgery. Once a hospital has installed a da Vinci Surgical System,
our clinical sales representatives help drive the utilization of the system,
and our technical service representatives provide service and maintenance for
the system.
Competition
We consider our primary competition to be existing open surgery, MIS, drug
therapies, radiation treatment and emerging interventional surgical approaches.
Our success depends in part on convincing hospitals, surgeons and patients that
the demonstrated benefits associated with da Vinci surgery are superior to other
techniques. We also face competition from several companies that are developing
new approaches and products for the MIS market. Because many of these developments
are aimed at MIS, we believe that our da Vinci Surgical System may actually
prove complementary to these new technologies.
In addition, a limited number of companies are using or planning to use robots
and computers in surgery, including Armstrong Healthcare Ltd., Hitachi Ltd.,
MicroDexterity Systems, Inc., Sinters SA, Terumo Medical Corporation, and Toshiba,
Inc. Our revenues may be reduced or eliminated if our competitors develop and
market products that are more effective or less expensive than our products.
Company Address: 1020 Kifer Road Sunnyvale 94086 CA
Company Phone Number: 523-2100 Stock Exchange / Ticker: NASDAQ ISRG
|
|
|
|
|
Stock Performances by Major Competitors |
|
|
Product Service News
Published Thu, Mar 14 2024 8:30 PM UTC
Intuitive Announces FDA Clearance of Fifth-Generation Robotic System, da Vinci 5Intuitive Surgical, a global leader in robotic-assisted surgery, recently made an exciting announcement about the FDA clearance of their fifth-generation robotic system, da Vinci 5. This latest development builds on decades of Intuitive's pioneering technology and years of experience, further cem...
|
Intuitive Surgical Inc
Intuitive Surgical Inc, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, has displayed impressive financial results in the fiscal span ending on December 31, 2023. The company reported revenue of $1.93 billion, showing a significant increase of 16.508% year on year and a notable growth of 10.613% quarter on quarter. Additionally, income per share saw a substantial increase of 84.06% to $1.70, with a sequential growth of 46.88%. Intuitive Surgical Inc has outperformed its sector peers in the Medical Equipment & Supplies industry, as the sector only saw a 10.82% increase in top-line revenue during the same period. This indicates that the company has a strong competitive advantage in the market. Moreover, the company's net earnings for the fiscal span ending December 31, 2023, amounted to $610.7 million, demonstrating an impressive growth of 81.38% compared to the previous year's net earnings of $336.7 million.
|
Intuitive Surgical Inc
Intuitive Surgical Inc: Strong Financial Performance and Promising Future Prospects Intuitive Surgical Inc, a leading medical equipment and supplies company, has impressed investors with its exceptional financial results for the fiscal span ending September 30, 2023. The company reported a significant increase in earnings per share (EPS) by 28.89% to $1.16 per share compared to the previous year period. Furthermore, revenue witnessed a commendable growth of 11.93% to $1.74 billion, showcasing the company's resilience in the face of challenging market conditions. The Medical Equipment & Supplies industry has faced numerous hurdles in recent times, with several companies experiencing a decline in their business. However, Intuitive Surgical Inc has proven its capability to withstand these challenges and has managed to achieve revenue improvement, setting it apart from its peers in the sector. This growth in revenue demonstrates the company's ability to adapt and succeed, even in a highly competitive environment.
|
Intuitive Surgical Inc
Intuitive Surgical Inc, a leading Medical Equipment & Supplies company, has recently reported impressive financial results for their most recent fiscal period. The company saw a significant jump in profit per share, with a 38.82% increase to $1.18 per share. This was accompanied by a revenue advance of 15.36% to $1.76 billion, compared to the previous year period. In comparison to the previous financial reporting period, income per share surged by 18% from $1.00 per share, while revenue increased by 3.52% from $1.70 billion. These positive financial indicators reflect the company's strong performance and growth. Net earnings also showed a substantial increase of 35.84%, reaching $426.000 million in the financial span ending June 30, 2023, compared to $313.600 million reported a year ago. Intuitive Surgical Inc also highlighted its improving profit margins, with a rise in net margin to 24.26% and an increase in operating margin to 26.38% in the financial span ending June 30, 2023. These improved margins indicate the company's ability to generate higher returns on its investments and operational efficiency.
|
Per Share |
Current |
Earnings (TTM) |
5.04 $ |
Revenues (TTM) |
19.93 $
|
Cash Flow (TTM) |
3.27 $ |
Cash |
14.61 $
|
Book Value |
37.48 $
|
Dividend (TTM) |
0 $ |
|
Per Share |
|
Earnings (TTM) |
5.04 $
|
Revenues (TTM) |
19.93 $ |
Cash Flow (TTM) |
3.27 $ |
Cash |
14.61 $
|
Book Value |
37.48 $ |
Dividend (TTM) |
0 $ |
|
|
|
Instruments & accessories |
|
Segment |
|
|
of total Revenue |
Systems |
|
Segment |
|
|
of total Revenue |
Services & training |
|
Segment |
|
|
of total Revenue |
|
|
|